{'fraction_non_alphanumeric': 0.030612244897959183, 'fraction_numerical': 0.023809523809523808, 'mean_word_length': 5.2, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Torsades de Pointes and QT Prolongation Due to a Combination of Loratadine and Amiodarone

ATAR, S., et al.: Torsades de Pointes and QT Prolongation Due to a Combination of Loratadine and Amiodarone. Torsades de pointes (TdP) has not been previously reported with loratadine. A 73‐year old woman on chronic treatment with amiodarone for atrial fibrillation received loratadine and presented with syncope and multiple episodes of TdP. We suggest that QT interval should be monitored whenever loratadine is co‐administered with drugs that may potentially prolong QT. (PACE 2003; 26:785–786)